Ruth Zárate

4.5k total citations · 1 hit paper
34 papers, 2.5k citations indexed

About

Ruth Zárate is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Ruth Zárate has authored 34 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 16 papers in Oncology and 14 papers in Cancer Research. Recurrent topics in Ruth Zárate's work include Colorectal Cancer Treatments and Studies (13 papers), MicroRNA in disease regulation (9 papers) and Cancer-related molecular mechanisms research (7 papers). Ruth Zárate is often cited by papers focused on Colorectal Cancer Treatments and Studies (13 papers), MicroRNA in disease regulation (9 papers) and Cancer-related molecular mechanisms research (7 papers). Ruth Zárate collaborates with scholars based in Spain, Italy and United States. Ruth Zárate's co-authors include Eva Bandrés, Jesús García‐Foncillas, Natalia Ramírez, Nerea Bitarte, Xabier Agirre, Raquel Malumbres, Elena Cubedo, Valentina Boni, I. Moreno and Mariano Monzó and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and International Journal of Molecular Sciences.

In The Last Decade

Ruth Zárate

33 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues.

2006 706 citations Eva Bandrés, Elena Cubedo et al. Molecular Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ruth Zárate Spain	18	1.9k	1.8k	525	193	179	34	2.5k
Dario Palmieri United States	30	1.8k 0.9×	1.2k 0.7×	609 1.2×	316 1.6×	107 0.6×	62	2.6k
Lian‐Yue Yang China	31	1.7k 0.9×	1.1k 0.6×	424 0.8×	236 1.2×	194 1.1×	57	2.4k
Selma Pennacchietti Italy	10	1.1k 0.6×	661 0.4×	565 1.1×	344 1.8×	223 1.2×	11	1.9k
Tomás Bonome United States	15	1.2k 0.6×	643 0.4×	457 0.9×	211 1.1×	211 1.2×	23	2.0k
Li-Bing Song China	25	1.6k 0.9×	550 0.3×	788 1.5×	182 0.9×	362 2.0×	32	2.2k
Haizhu Song China	30	1.7k 0.9×	1.3k 0.7×	684 1.3×	320 1.7×	125 0.7×	62	2.5k
Dingzhi Huang China	21	1.4k 0.7×	1.2k 0.7×	499 1.0×	364 1.9×	109 0.6×	76	2.0k
Kwan Man Hong Kong	17	1.7k 0.9×	1.3k 0.7×	743 1.4×	138 0.7×	152 0.8×	24	2.5k
Karin Collett Norway	15	1.1k 0.6×	626 0.3×	640 1.2×	205 1.1×	190 1.1×	31	1.9k
Brian P. James United States	15	943 0.5×	676 0.4×	690 1.3×	250 1.3×	237 1.3×	27	1.6k

Countries citing papers authored by Ruth Zárate

Since Specialization

Citations

This map shows the geographic impact of Ruth Zárate's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruth Zárate with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruth Zárate more than expected).

Fields of papers citing papers by Ruth Zárate

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruth Zárate. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruth Zárate. The network helps show where Ruth Zárate may publish in the future.

Co-authorship network of co-authors of Ruth Zárate

This figure shows the co-authorship network connecting the top 25 collaborators of Ruth Zárate. A scholar is included among the top collaborators of Ruth Zárate based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruth Zárate. Ruth Zárate is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Acosta-Colman, I., et al.. (2022). Association of class II HLA alleles with susceptibility to develop immune‐mediated diseases in Paraguayan patients. International Journal of Immunogenetics. 50(1). 12–18. 1 indexed citations

Rodríguez, J., Ruth Zárate, Eva Bandrés, et al.. (2012). Fc gamma receptor polymorphisms as predictive markers of Cetuximab efficacy in epidermal growth factor receptor downstream-mutated metastatic colorectal cancer. European Journal of Cancer. 48(12). 1774–1780. 63 indexed citations

Boni, Valentina, Inés López, Marisol González-Huarriz, et al.. (2012). Identification of predictive circulating biomarkers of bevacizumab-containing regimen efficacy in pre-treated metastatic colorectal cancer patients. British Journal of Cancer. 107(2). 287–290. 35 indexed citations

Rodríguez, J., Valentina Boni, Andrea Hernández, et al.. (2011). Association of RRM1 –37A>C polymorphism with clinical outcome in colorectal cancer patients treated with gemcitabine-based chemotherapy. European Journal of Cancer. 47(6). 839–847. 18 indexed citations

Boni, Valentina, Nerea Bitarte, Ion Cristóbal, et al.. (2010). miR-192/miR-215 Influence 5-Fluorouracil Resistance through Cell Cycle-Mediated Mechanisms Complementary to Its Post-transcriptional Thymidilate Synthase Regulation. Molecular Cancer Therapeutics. 9(8). 2265–2275. 139 indexed citations

Boni, Valentina, Ruth Zárate, Eva Bandrés, et al.. (2010). Role of primary miRNA polymorphic variants in metastatic colon cancer patients treated with 5-fluorouracil and irinotecan. The Pharmacogenomics Journal. 11(6). 429–436. 93 indexed citations

Zárate, Ruth, Javier Rodríguez, Eva Bandrés, et al.. (2010). Oxaliplatin, irinotecan and capecitabine as first-line therapy in metastatic colorectal cancer (mCRC): a dose-finding study and pharmacogenomic analysis. British Journal of Cancer. 102(6). 987–994. 40 indexed citations

Rodríguez, Javier, Nerea Bitarte, Ruth Zárate, et al.. (2010). Dose-finding study and pharmacogenomic analysis of fixed-rate infusion of gemcitabine, irinotecan and bevacizumab in pretreated metastatic colorectal cancer patients. British Journal of Cancer. 103(10). 1529–1535. 16 indexed citations

Bandrés, Eva, Nerea Bitarte, Fernando Arias, et al.. (2009). microRNA-451 Regulates Macrophage Migration Inhibitory Factor Production and Proliferation of Gastrointestinal Cancer Cells. Clinical Cancer Research. 15(7). 2281–2290. 302 indexed citations

10.

Bandrés, Eva, Xabier Agirre, Nerea Bitarte, et al.. (2009). Epigenetic regulation of microRNA expression in colorectal cancer. International Journal of Cancer. 125(11). 2737–2743. 369 indexed citations

11.

Boni, Valentina, Eva Bandrés, Ruth Zárate, et al.. (2009). MicroRNAs as a New Potential Therapeutic Opportunity in Gastrointestinal Cancer. Oncology. 77(Suppl. 1). 75–89. 5 indexed citations

12.

Viúdez, A., Ruth Zárate, Marı́a J. Garrido, et al.. (2009). Dose escalation of capecitabine in combination with biweekly cetuximab and hepatic arterial infusion (HAI) of oxaliplatin in patients with liver metastases of colorectal cancer: Preliminary clinical results. Journal of Clinical Oncology. 27(15_suppl). e15080–e15080. 1 indexed citations

13.

Ramírez, Natalia, Eva Bandrés, Alfons Navarro, et al.. (2008). Epigenetic events in normal colonic mucosa surrounding colorectal cancer lesions. European Journal of Cancer. 44(17). 2689–2695. 28 indexed citations

14.

Bandrés, Eva, Xabier Agirre, Natalia Ramírez, Ruth Zárate, & Jesús García‐Foncillas. (2007). MicroRNAs as Cancer Players: Potential Clinical and Biological Effects. DNA and Cell Biology. 26(5). 273–282. 57 indexed citations

15.

González-Santiago, Santiago, Ruth Zárate, Juan de la Haba-Rodríguez, et al.. (2007). CYP2D6*4 polymorphism as blood predictive biomarker of breast cancer relapse in patients receiving adjuvant tamoxifen. Journal of Clinical Oncology. 25(18_suppl). 590–590. 13 indexed citations

16.

Zárate, Ruth, et al.. (2007). GSTP1 and MTHFR Polymorphisms Are Related with Toxicity in Breast Cancer Adjuvant Anthracycline-Based Treatment. Current Drug Metabolism. 8(5). 481–486. 14 indexed citations

17.

Bandrés, Eva, Elena Cubedo, Xabier Agirre, et al.. (2006). Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues.. Molecular Cancer. 5(1). 29–29. 706 indexed citations breakdown →

18.

Bandrés, Eva, et al.. (2006). Epidermal growth factor receptor (EGFR) polymorphisms and survival in head and neck cancer patients. Oral Oncology. 43(7). 713–719. 35 indexed citations

19.

García‐Foncillas, Jesús, et al.. (2006). Proteomic analysis in cancer research: potential application in clinical use. Clinical & Translational Oncology. 8(4). 250–261. 22 indexed citations

20.

Bandrés, Eva, Esther Andion, Victoria Catalán, et al.. (2005). Gene expression profile induced by BCNU in human glioma cell lines with differential MGMT expression. Journal of Neuro-Oncology. 73(3). 189–198. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact